Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus

NCT05886088 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

597

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LID104
DRUG: Dapagliflozin
DRUG: Linagliptin

Sponsor

EMS